Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative.
Groechel RC, Tripodis Y, Alosco ML, Mez J, Qiu WQ, Mercier G, Goldstein L, Budson AE, Kowall NW, Killiany RJ; Alzheimer’s Disease Neuroimaging Initiative. Groechel RC, et al. Among authors: qiu wq. Neurobiol Aging. 2023 Jul;127:33-42. doi: 10.1016/j.neurobiolaging.2023.03.005. Epub 2023 Mar 10. Neurobiol Aging. 2023. PMID: 37043881
Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A, Hur JY, Zheng H, Li H, Fine R, Mwamburi M, Sun X, Kowall N, Stern RA, Qiu WQ. Zhu H, et al. Among authors: qiu wq. Mol Psychiatry. 2015 Feb;20(2):252-62. doi: 10.1038/mp.2014.17. Epub 2014 Mar 11. Mol Psychiatry. 2015. PMID: 24614496 Free PMC article.
Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
Zhu H, Xue X, Wang E, Wallack M, Na H, Hooker JM, Kowall N, Tao Q, Stein TD, Wolozin B, Qiu WQ. Zhu H, et al. Among authors: qiu wq. Neuropharmacology. 2017 Jun;119:170-181. doi: 10.1016/j.neuropharm.2017.03.030. Epub 2017 Mar 28. Neuropharmacology. 2017. PMID: 28363773 Free PMC article.
An amylin analog used as a challenge test for Alzheimer's disease.
Zhu H, Stern RA, Tao Q, Bourlas A, Essis MD, Chivukula M, Rosenzweig J, Steenkamp D, Xia W, Mercier GA, Tripodis Y, Farlow M, Kowall N, Qiu WQ. Zhu H, et al. Among authors: qiu wq. Alzheimers Dement (N Y). 2017 Jan;3(1):33-43. doi: 10.1016/j.trci.2016.12.002. Alzheimers Dement (N Y). 2017. PMID: 28503657 Free PMC article.
Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau.
Frank B, Ally M, Brekke B, Zetterberg H, Blennow K, Sugarman MA, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkina I, Turk KW, Budson AE, O'Connor MK, Au R, Goldstein LE, Jun GR, Kowall NW, Stein TD, McKee AC, Killiany R, Qiu WQ, Stern RA, Mez J, Alosco ML. Frank B, et al. Among authors: qiu wq. Alzheimers Dement. 2022 Aug;18(8):1523-1536. doi: 10.1002/alz.12508. Epub 2021 Dec 2. Alzheimers Dement. 2022. PMID: 34854549 Free PMC article.
168 results